Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk ・Combines Mount Sinai’s world-class AI and ...

Intramolecular charge transfer (ICT) is one of the most important photophysical mechanisms in organic fluorophores. Among ICT processes, TICT ...

Rapid advances in artificial intelligence, machine learning, and data-driven computational modeling have opened unprecedented opportunities to transform ...

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript March 12, 2026 HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.15728 EPS, expectations were $-0.1375. Operator: ...

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...

A massive pipe burst out of the road in Osaka, Japan, bringing traffic to a screeching halt. The pipe is 11.5 feet in ...

No matter your age, it’s never too late to learn something new—especially in a world that’s constantly changing. With ...

Global Digital Biomarkers Market OverviewThe global digital biomarkers market is poised for rapid expansion and is expected ...

Worcester Polytechnic Institute (WPI) researchers have used a form of artificial intelligence (AI) to analyze anatomical changes in the brain and predict Alzheimer's disease with nearly 93% accuracy.

Introduction Incidental pulmonary nodules (IPNs) are commonly encountered on chest radiographs (CXRs) performed for routine ...